CN Patent
CN104926734B — 氟班色林的制备方法
Assigned to SUZHOU LIXIN PHARMACEUTICAL Co.,Ltd. · Expires 2017-04-05 · 9y expired
What this patent protects
本发明揭示了一种氟班色林(Flibanserin)的制备方法:以易得的间氨基三氟甲苯、三(2‑卤素乙基)胺和邻硝基苯胺为原料,采用环合、取代、还原及缩合等经典单元反应制得氟班色林。该制备方法原料易得、工艺简洁、收率较高且经济环保,为氟班色林的工业化生产提供了一条新的制备途径。
USPTO Abstract
本发明揭示了一种氟班色林(Flibanserin)的制备方法:以易得的间氨基三氟甲苯、三(2‑卤素乙基)胺和邻硝基苯胺为原料,采用环合、取代、还原及缩合等经典单元反应制得氟班色林。该制备方法原料易得、工艺简洁、收率较高且经济环保,为氟班色林的工业化生产提供了一条新的制备途径。
Drugs covered by this patent
- Addyi (FLIBANSERIN) · Sprout Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.